Skip to main content
CHC logo

CHC — Investor Relations & Filings

Ticker · 4164 ISIN · TW0004164009 TW Wholesale and retail trade
Open in API
Filings indexed 2,275 across all filing types
Latest filing 2018-05-31 Director's Dealing
Country TW Taiwan
Listing TW 4164

About CHC

www.chcg.com

CHC Healthcare Group is a provider of comprehensive medical equipment, technology, and management services. The company offers one-stop solutions ranging from equipment distribution and leasing to operational consulting and hospital management. Its extensive portfolio covers specialized fields such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, dentistry, and rehabilitation. Representing over 30 international brands, the group is a major distributor of high-end medical devices and a leader in oncology equipment. Beyond equipment sales and maintenance, the company has expanded into long-term care, radiation sterilization services, and chain pharmacy channels. With a focus on smart healthcare and advanced medical technologies, the group supports healthcare providers through technical maintenance, personnel training, and integrated department construction across the Asia-Pacific region.

Recent filings

Filing Released Lang Actions
107年5月30日內部人設質解質
Director's Dealing Classification · 100% confidence The document contains a table listing share pledge changes involving company directors and their related parties, including details such as pledge dates, number of shares pledged, and pledgees. The presence of director names and share transactions related to pledges indicates this is a report of personal share transactions by company directors or executives. The document is short and specific to insider share dealings, matching the definition of Director's Dealing filings.
2018-05-31 Chinese
107年05月僑外投資持股
Major Shareholding Notification Classification · 95% confidence The document is a statistical table showing shareholding information of overseas and mainland China investors, including changes before and after a shareholder meeting date. It includes details on share counts and categories but does not contain financial statements, management discussion, or report narratives. The document length is short (1077 characters) and it is a regulatory disclosure of shareholding changes related to a shareholder meeting. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels. There is no indication of it being an announcement of a report publication or a full report itself.
2018-05-22 Chinese
代子公司九和生物科技(股)公司公告董事會決議減資
Capital/Financing Update Classification · 95% confidence The document is a short announcement (739 characters) from a company about a board resolution regarding capital reduction by a subsidiary. It includes details such as the date of the board meeting, amount of capital reduction, shares cancelled, and post-reduction capital. There is no detailed financial report or analysis, only a notification of a board decision related to capital structure. This fits the category of Capital/Financing Update (CAP) rather than a full financial report or other categories. The document is not a report publication announcement or regulatory filing fallback because it contains substantive information about a financing event. Therefore, the classification is CAP with high confidence.
2018-05-17 Chinese
代重要子公司醫世紀健康管理顧問(股)公司公告董事會決議 減資
Capital/Financing Update Classification · 95% confidence The document is a short announcement (747 characters) from a listed company (4164 承業醫) regarding a board resolution about capital reduction of a major subsidiary. It includes details such as the date of the board meeting, amount of capital reduction, shares cancelled, and other related information. There is no detailed financial data or comprehensive report content. The document is an official announcement of a board decision related to capital structure changes, specifically a capital reduction. This fits the category of Capital/Financing Update (CAP). The document is not a full report, nor a simple notification of report publication, so RPA is not appropriate. It is not a regulatory filing of miscellaneous nature (RNS) because it is specific to capital changes. Therefore, the best classification is CAP with high confidence.
2018-05-17 Chinese
代重要子公司華霖(股)公司公告董事會決議減資
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement (739 characters) about a board resolution regarding capital reduction by a subsidiary company. It includes details such as the date of the board meeting, amount of capital reduction, and shares cancelled. There is no financial statement or comprehensive report content. The document is a regulatory announcement about a capital structure change, specifically a capital reduction, which fits the category of Share Issue/Capital Change (SHA). It is not a full report or financial statement, nor is it a simple notification of a report publication. Therefore, the appropriate classification is SHA.
2018-05-17 Chinese
代子公司九和生物科技(股)公司公告董事會決議不分配股利
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement from a company (4164 承業醫) regarding a board resolution not to distribute dividends. It specifies the board meeting date and the decision about dividends (no dividend distribution). The document length is only 482 characters, indicating it is a brief announcement rather than a full report. It does not contain financial statements or detailed analysis, but rather a specific corporate action related to dividends. According to the filing definitions, announcements about dividend amounts or decisions fall under 'Notice of Dividend Amount (DIV)'.
2018-05-17 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.